• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/35

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

35 Cards in this Set

  • Front
  • Back
electrical properties of the heart
-SA node: pacemaker for the heart
-AV node: impulses originating in atria must travel through AV node to reach ventricles
-His-Purkinje fibers: conduct electrical excitation very rapidly to all parts of ventricles
cardiac action potentials
-cardiac cells initiate and conduct conduct action potentials consisting of self-propagating waves of depolarization followed by repolarization
-generated by movement of ions into and out of cells
-ion fluxes happen through specific channels in the cell membrane
fast potential locations
occur in His-Purkinje fibers and in atrial and ventricular muscles
fast potential phases
0) depolarization
1) (partial) repolarization
2) plateau
3) repolarization
4) stable potential
slow potential locations
occur in cells of SA and AV nodes
slow potential phases
0) slow depolarization mediated by calcium influx
1) absent
2 and 3) not significant
4) depolarization
atrial fibrillation
-supraventricular
-most common sustained dysrhythmia
-treated with beta blockers (e.g. atenolol or metoprolol)
-treated with warfarin for stroke patients
atrial flutter
-supraventricular
-250-300 bpm
-treatment: cardioversion
sustained supraventricular tachycardia
-supraventricular
-150-200 bpm
-first line of treatment is carotid sinus massage or Valsalva's maneuver
-second line of treatment is IV beta blocker or calcium channel blocker
sustained ventricular tachycardia
-dangerous
-150-200 bpm
-treatment: cardioversion or IV amiodarone
ventricular fibrillation
-life-threatening emergency
-treatment: defibrillation
ventricular premature contractions/beats
(VPCs or VPBs)
-beats occur prematurely in cardiac cycle
-treated with beta blocker
digoxin-induced ventricular dysrhythmias
-treatment: lidocaine or phenytoin
-can almost always be controlled
torsades de pointes
-ventricular dysrhythmia
-atypical, undulating, rapid, ventricular tachydysrhythmia that can evolve into vfib
-treatment: IV magnesium plus cardioversion
classes of antidysrhythmics
I: sodium channel blockers
II: beta blockers
III: potassium channel blockers
IV: calcium channel blockers
indications and therapeutic effects of QUINIDINE (class IA)
indications: supraventricular and ventricular dysrhythmias
effects on heart:
-blocks sodium channels
-slows impulse conduction
-delays repolarization
-blocks vagal input to the heart
-widens QRS complex
-prolongs QT interval
side effects of QUINIDINE
(class IA)

-diarrhea
-cinchonism
-cardiotoxicity
-arterial embolism
-alpha-adrenergic blockade resulting in hypotension
-hypersensitivity reactions
drug interactions of QUINIDINE
(class IA)

-digoxin
therapeutic effects of LIDOCAINE (class IB)
-blocks sodium channel
-slows conduction in all areas of the heart
-reduces automaticity of ventricles and His-Purkinje system
-accelerates repolarization

other class IB agents: phenytoin and mexiletine
side effects of LIDOCAINE
(class IB)

-CNS effects
-paresthesias
-drowsiness
-confusion
flecainide and propafenone (class IC)
-block cardiac sodium channels
-delay ventricular repolarization
-can exacerbate existing dysrhythmias and create new ones
major components of an ECG
-P wave: atrial depolarization
-QRS complex: ventricular depolarization
-T wave: ventricular repolarization
PROPANOLOL (Inderal)
-non-selective beta-adrenergic antagonist
-class II
-decreased automaticity of SA node
-decreased conduction velocity through AV node
-decreased myocardial contractility
PROPANOLOL (Inderal) indications and therapeutic effects
(class II)
-dysrhythmias caused by excessive sympathetic stimulation
-supraventricular tachydysrhythmias
-suppression of excessive
discharge
-slowing of ventricular rate
adverse effects of PROPANOLOL (Inderal)
-heart block
-heart failure
-AV block
-sinus arrest
-hypotension
-bronchospasm in asthma patients
BRETYLIUM (class III) indications and therapeutic effects
indications:
-vfib
-vtach
therapeutic effects:
-delay repolarization of fast potentials
-prolonged QT interval
BRETYLIUM side effects
(class III)

-profound persistent hypertension
AMIODARONE (Cordarone, Pacerone) (class III) indications
-for life-threatening ventricular dysrhythmias only
-recurrent vfib
-recurrent hemodynamically unstable vtach
AMIODARONE (Cordarone, Pacerone)
therapeutic effects
(class III)
-reduces automaticity in SA node
-negative inotropic
-reduces conduction velocity
-QRS widening
-prolonged PR and QT intervals
AMIODARONE (Cordarone, Pacerone) side effects
(class III)
-pulmonary toxicity
-cardiotoxicity
-toxicity in pregnancy and breastfeeding
-corneal microdeposits
-optic neuropathy
AMIODARONE (Cordarone, Pacerone) drug interactions
-quinidine
-digoxin
-procainamide
-diltiazem
-phenytoin
-warfarin
VERAPAMIL and DILTIAZEM (class IV) indications and therapeutic effects
indications: slow ventricular rate due to afib or atrial flutter, termination of SVT
therapeutic effects:
-reduces SA node automaticity
-slows AV node conduction
-negative inotropic
VERAPAMIL and DILTIAZEM adverse effects
(class IV)
-bradycardia
-hypotension
-AV block
-heart failure
-peripheral edema
-constipation
ADENOSINE indications and therapeutic effects
indication: paroxysmal SVT (supraventricular tachycardia)
therapeutic effects:
-decreases SA node automaticity
-slows conduction through AV node
-prolonged PR interval
ADENOSINE side effects and drug interactions
side effects:
-sinus bradycardia
-dyspnea
-hypotension
-FACIAL FLUSHING
drug interactions:
-methylxanthines
-dipyridamole